New Jersey Assembly Bill 4550: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.
New Jersey · 2026-2027 Regular Session
What it does
Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.
Latest action
Introduced, Referred to Assembly Financial Institutions and Insurance Committee (2026-03-10)
See how A 4550 affects you on CapitolKey
Browse more bills · CapitolKey home